RSS   Newsletter   Contact   Advertise with us

Acasti Pharma appoints Donald Olds to board

Staff Writer | Laval, QC, Canada | April 30, 2018
Donald OldsAcasti Pharma, a biopharmaceutical company, announced that it has appointed Donald Olds to its board of directors and audit committee.
Mr. Olds is President and Chief Executive Officer of the NEOMED Institute.

Prior to NEOMED, he was the Chief Operating Officer of Telesta Therapeutics where he was responsible for finance and investor relations, manufacturing operations, business development, human resources and strategy.

In 2016, he led the successful sale of Telesta to a larger public biotechnology company.

Prior to Telesta, he was President and Chief Executive Officer of Presagia Corp., and Chief Financial Officer and Chief Operating Officer of Aegera Therapeutics, where he was responsible for clinical operations, business development, finance, and mergers and acquisitions.

Mr. Olds is currently Director of Goodfood Market Corp, Chairman of Oxfam Quebec and Director of Presagia Corp.

He holds an MBA (Finance & Strategy) and M.Sc. (Renewable Resources) from McGill University.